Reduced-representation Phosphosignatures Measured by Quantitative Targeted MS Capture Cellular States and Enable Large-scale Comparison of Drug-induced Phenotypes

Abstract

Profiling post-translational modifications represents an alternative dimension to gene expression data in characterizing cellular processes. Many cellular responses to drugs are mediated by changes in cellular phosphosignaling. We sought to develop a common platform on which phosphosignaling responses could be profiled across thousands of samples, and created a targeted MS assay that profiles a reduced-representation set of phosphopeptides that we show to be strong indicators of responses to chemical perturbagens.To develop the assay, we investigated the coordinate regulation of phosphosites in samples derived from three cell lines treated with 26 different bioactive small molecules. Phosphopeptide analytes were selected from these discovery studies by clustering and picking 1 to 2 proxy members from each cluster. A quantitative, targeted parallel reaction monitoring assay was developed to directly measure 96 reduced-representation probes. Sample processing for proteolytic digestion, protein quantification, peptide desalting, and phosphopeptide enrichment have been fully automated, making possible the simultaneous processing of 96 samples in only 3 days, with a plate phosphopeptide enrichment variance of 12%. This highly reproducible process allowed ∼95% of the reduced-representation phosphopeptide probes to be detected in ∼200 samples.The performance of the assay was evaluated by measuring the probes in new samples generated under treatment conditions from discovery experiments, recapitulating the observations of deeper experiments using a fraction of the analytical effort. We measured these probes in new experiments varying the treatments, cell types, and timepoints to demonstrate generalizability. We demonstrated that the assay is sensitive to disruptions in common signaling pathways (e.g. MAPK, PI3K/mTOR, and CDK). reduced-representation assay a platform for the of across a of for thousands of We the assay highly for of and and of Profiling post-translational modifications represents an alternative dimension to gene expression data in characterizing cellular processes. Many cellular responses to drugs are mediated by changes in cellular phosphosignaling. We sought to develop a common platform on which phosphosignaling responses could be profiled across thousands of samples, and created a targeted MS assay that profiles a reduced-representation set of phosphopeptides that we show to be strong indicators of responses to chemical develop the assay, we investigated the coordinate regulation of phosphosites in samples derived from three cell lines treated with 26 different bioactive small molecules. Phosphopeptide analytes were selected from these discovery studies by clustering and picking 1 to 2 proxy members from each cluster. A quantitative, targeted parallel reaction monitoring assay was developed to directly measure 96 reduced-representation probes. Sample processing for proteolytic digestion, protein quantification, peptide desalting, and phosphopeptide enrichment have been fully automated, making possible the simultaneous processing of 96 samples in only 3 days, with a plate phosphopeptide enrichment variance of 12%. This highly reproducible process allowed ∼95% of the reduced-representation phosphopeptide probes to be detected in ∼200 performance of the assay was evaluated by measuring the probes in new samples generated under treatment conditions from discovery experiments, recapitulating the observations of deeper experiments using a fraction of the analytical effort. We measured these probes in new experiments varying the treatments, cell types, and timepoints to demonstrate generalizability. We demonstrated that the assay is sensitive to disruptions in common signaling pathways (e.g. MAPK, PI3K/mTOR, and CDK). reduced-representation assay a platform for the of across a of for thousands of We the assay highly for of and and of of and is of in the the of in of gene expression data from samples to and gene expression and data for data an the of reaction profiles from with and of these profiles to develop the to small and a new for of parallel reaction represents a to and only of cellular and the post-translational modifications to the and for these and to changes treatment and are mediated by changes of post-translational modifications on in is to be a strong of cellular signaling of in and gene the to in the in disruptions in in on and of in protein in protein changes in cellular of of protein to the for and of the protein in and of of phosphosignaling is to be in A assay 1 a of in is a that in signaling of of to and to from to and and in that We that phosphosignaling responses to and cellular that to gene expression is of for these profiles of these post-translational of protein are and the of and are in are in the of in protein A to protein protein of the protein is of the of and in cell signaling analytical to for protein have been have been developed to signaling of of to and to and by peptide by for protein and have been to and from proteolytic of and for and of for phosphopeptide enrichment for by with highly sensitive these enrichment have studies in in and changes in pathways protein of and to for and and to and in gene expression be highly to have reproducible observations of phosphopeptide analytes across of samples generated under different with the and sensitive MS is possible to measure of the across experiments using across small of experiments are in processing and data of and for of of the an A for and of protein in in data in the of the is a is possible to and phosphosites in a of these we that is mediated by a protein and that of thousands of on protein We that the of to that is in the cellular by and that the of on coordinate could a set of highly phosphopeptide probes. This is with by phosphosignaling cell lines with different to were profiled to that were in parallel pathways of under and conditions of and of a was to develop the reduced-representation assay that is the for the assay of of the of expression to and gene expression a reduced-representation set of phosphopeptide probes using a targeted MS could be a and to changes in phosphosignaling in to and an assay could and cell cell using to in the A was by and developed a targeted assay to in in to by from data A protein assay for cellular targeted could and for across in to a and of three a discovery we a set of phosphopeptide probes from a we develop a phosphopeptide assay that data that observations for and a we the of the assay to and and demonstrate discovery we data samples that 26 chemical in three different cell lines using phosphopeptide enrichment and these data we selected phosphosites from of that regulation across discovery We a targeted parallel reaction monitoring assay these phosphopeptide probes using and in developed that proteolytic digestion, protein quantification, peptide desalting, and phosphopeptide enrichment from 96 samples in of the assay to a of of the assay was to samples under conditions to in discovery experiments to we could the using only the reduced-representation a fraction of the for deeper in we conditions to the treatments, cell types, and measured with the of that the assay could profiles of the under which was developed and to demonstrate that the assay is to disruptions of signaling pathways of We assay phosphopeptide probes in a This assay is a phosphosignaling of Profiling assay the of by targeted in that to be of We that the assay highly for and of and of of chemical and to of is these the for to were in with and were in with and were in with and and and were of and for cell were in with and were in with and were in with and were to to and were from with the of which was the of ∼95% were treated with the in and for the were with and by were for 2 was and the cell was in cell and phosphopeptide and for discovery in a new discovery experiments, we to of these experiments, we the and the drugs in the and in and in each were were using of treatment for each of the discovery data a that for each of the 26 be in This data set been in with experiments, were in of the of the assay are to were from ∼95% were treated with the in for the were with in plate in 1 2 1 2 3 and by were for and to phosphopeptide cell were by for of were with by in cell cell of were in each of and and ∼95% were treated with the in for were by with and for 2 was and the cell were in cell and phosphopeptide cell were for in 1 2 1 2 3 were for and protein of the were measured protein assay of protein was for with and for with were to 2 with were with in a on a was by the samples to a of samples were a for were using and to of post-translational modifications by Phosphopeptide enrichment was using that were by with to were in were for with for each for Phosphopeptide enrichment was enrichment for by was on and for and of for using were with 2 of 2 of and 2 of were and with of and of were from with 3 of and with of from with were on a a of cell were for in 1 2 1 2 3 were for and protein of the were measured protein assay of protein was to a platform for in in to 2 in and with in was by the samples to a of samples were a in a plate for were using and to samples were in that for enrichment and to an were with with and with were with and samples were were a of 2 were with and were with were to and using to the A is were for in 1 2 1 2 3 were for and protein of the were measured protein assay of protein was to a platform for in in to 2 in and with in was by the samples to a of samples were a in a plate for were using and to samples were in that for enrichment and to an that we the enrichment from the were with with and with were with samples were and were were with and were with were to and using to the A is in Phosphopeptide using was to 3 with the data were using a data were using A of was using an for each to of the in these data were in the of and were we and that been in a of the samples in We that targeted for these to a data for we created for each to in the with the of a from discovery to targeted assay for data three the conditions were using a with a with a was under to with and were in and were with a from of and and for and were a A MS was a of from to was by a an were and the was set the was set of post-translational modifications by were and the was set the were the of were selected from to were using the conditions the with the were in of phosphopeptide probes. were using a from of and for were a A MS was a of from to was by fully targeted 2 peptide was to for on the on the of of a of phosphopeptide probes. the experiments, were a with the with the MS was from to and with data have been in the and are to the targeted be MS were with the was and and the modifications were of of of and of allowed were for MS and for and were using by and were for and be in that were in of experiments were a data was for a in a we by of a on the and of of that in conditions of were variance was measured for each and with the of variance across experiments were of for and was We clustering of using clustering samples and using a of of these data was using the data to phosphopeptides were selected from each using an that data each by to in and data of that were selected be in were a an for and targeted with for reduced-representation phosphopeptide probes and for the phosphopeptide probes were on the of for and and phosphopeptide was using the of with samples and the of with were on the of using for each were by the of samples was in using with the and possible were using A was for each set of for a in a cell was the in to an A the three of in and the 3 of in that the A and is the of the possible of these A for of was to and the were using using the the is directly to the We set to develop a and targeted assay that could on the of cellular of process is in 1 We small that were to in We treated cell with these and We a small of and a of phosphosites were to be the of are across a of We that a set of could for a we were to of phosphosites that from which we selected We a reduced-representation targeted MS assay for these phosphopeptide probes We the assay in new samples under treatment conditions in discovery experiments to that the assay was We the assay on samples from new cell and that were for assay to demonstrate the of the assay under we phosphosignaling profiles from treated with of in a to demonstrate that the assay is sensitive to disruptions in common signaling MAPK, PI3K/mTOR, and cell experiments allowed to the of of we a data platform that the of phosphosignaling that be to drugs and and to drugs to to small with on we gene expression data in the for that the expression of of and was a set of expression is the phosphosites that be We highly be to the on the the of the data set of data for samples across cell lines and and each is the gene expression from of a treatment in a cell We by probes to of We these data in the that treatment with gene expression profiles We each for the of of are by the in were selected from with an on of the by in the the in we selected of a to on we selected 26 1 and 1 that we to be strong for of and across a of cell we measured the cellular by these 26 different with across three cell lines and in for a of experiments in data set we that were in of only these we and variance phosphosites were the data we clustering of the conditions and the detected phosphosites We the discovery data set with an reproducible responses of by phosphosites for conditions and could be we could phosphopeptide and a of the from are in 2 to these We show a to treatment across three cell lines in with of phosphosites across a set of that of treatment in the of the cell We a and is these cell lines are of a that in phosphosites to these clustering these in are a of the We demonstrate and across a set of in and is a in the treatment of conditions in the of and are to have of these across the and cell lines and a common of a of phosphosites the protein with the is of we a of a of that only to in show that are in common of of to in cellular we that these are and are on the of from these data is We an of phosphosites in the data set that to be across a of conditions we that the of a in to different treatment and across cell We that the of the in to have a strong and was by a enrichment the which that the were for with an of with in the data We that of the in the are to in in a in the with and This the of regulation of the by phosphosignaling in a are to be from deeper of the discovery data was the the the of which was to develop an phosphosignaling for We a to the of phosphosites that could be a small of to the This of signaling a fraction of the with This from the assay developed for the of that the of for monitoring expression have in a gene expression assay that of of the of expression A been by in the of signaling in A protein assay for cellular We by clustering on data in and we that to of the variance in the data We and measured the of these a of the data for of We a in the and on to set on clustering data that the phosphosites different We that the of to of the gene expression assay to we selected 2 phosphopeptide probes from each of the for a of phosphopeptides probes were using to of on the we developed a targeted assay to and highly and phosphopeptides across cell treated with of probes peptide probes could be the targeted assay for peptide peptide MS in a of 96 phosphopeptide probes in of the that we selected a of possible with a of and 96 probes A of assay a we the processing in a cell the processing protein a protein digestion, phosphopeptide and using and the simultaneous processing of 96 samples in only 3 days, with a plate phosphopeptide enrichment variance of using This highly reproducible process allowed ∼95% of the reduced-representation phosphopeptides in to for the of the are in and We were to phosphosignaling profiles in under 2 from the of cell to using assay by directly measuring the reduced-representation set of phosphopeptides across cell and signaling pathways from the of and by the phosphopeptides that were to the reduced-representation phosphopeptide set are in for each signaling are on a that is to the of in a that are in the set of A that a signaling is by a of of the signaling in that are different signaling and lines a of are We that these pathways be in the targeted assay by proxy the reduced-representation and demonstrate for of and of targeted data are using an for and targeted and data and are a of to reproducible are of data A the data is in that the assay could of to from we a of the conditions from discovery experiments and We the of these experiments in an of the data of the samples are by and of the probes are in each cell is the of the of the peptide to the and the is to the of from the a phosphopeptide is in a to are in data set data and we were to from of possible samples data from of the 96 probes. were of the probes were and probes were were in of be that a that we to the peptide that the was to the we could these to a We of from and to to samples treated with we that and in the phosphosignaling profiles that from and in the assay We that of the across cell in the for We an alternative of these in with in and We that alternative A of the of cell treated with with cell and treatment the across cell and the treatment each cell are in the the of is a of samples are and the phosphosignaling are in that of samples a strong the of of samples be and on we a of which that the assay is the the of the samples demonstrate strong treated with different on the observations from these strong members This that the profiles be in and and of the the from the treatment across cell types, characterizing the in the a treatment cell signaling pathways across cell types, the of a of the across different cell lines 1 that the on phosphosignaling across cell the of the and responses to the only a of the the of the the of the treatment each cell are of a the of the assay process across different strong 1 that are to be the and that is a strong to signaling responses in a the performance of the assay, we a with A the from a of probes is in is a we of phosphopeptide probes and that in with that we a in the responses of the demonstrate that we have selected analytes that have responses under a of cellular making for the signaling of the cell in clustering the in of in and with the and the making This that the of from be to and be for and that phosphosignaling. that the assay could in for we a using cell lines and that were assay We selected and derived from these of in We to the and with to of modifications regulation been to be for of and from in have been with and A of and in a an and phosphosignaling profiles generated from and are in we in of the we that profiles across cell We of responses to that the signaling of these in cell the and developed in the of phosphosignaling the we have that are the using assay the of by targeted data we show that these develop in the of to the that be the and signaling in by the observations in these observations were using the reduced-representation assay in a that was we were samples and demonstrate that the assay be to in cell types, a we an to demonstrate that the assay is to of We selected a of small that were to members of MAPK, PI3K/mTOR, and signaling of the the that with a from of and and to in is in was to measure the of and we samples and of We these experiments in the which the and and of and to and of of in the cell for profiles derived from these experiments are in are in profiles are to the and each of the each are in from to is from these profiles that the different generated a set of responses in the We that of the have only with of with the the the 3 This is of the with of and are and a and to have to profiles the only a strong of which the was developed a treatment for the of the cell for We the of of these for the different the profiles to a of the and signaling to be We derived from that were with to the to be we of the of samples each 3 samples with 3 samples, with and the for is in from the are on the which the of the we that were of that to be to the we to these of and we that to the that we from the This is to that of the the the in the the that in the pathways of the phosphosignaling with reduced-representation of the to of from the data was to develop a for a assay that could be to the of on cell signaling across generated under of cellular responses to drugs data and and of and for of of the an a from discovery to targeted assay for the of thousands of in samples, across conditions are and data discovery experiments that are and to data with we a targeted assay for a set phosphopeptide probes that a highly of the We these probes from discovery cell studies and the assay for under cell types, We that targeted for assay, data and the of phosphosignaling studies a fraction of the of discovery assay cellular phosphosignaling of profiles that be across small and of the the assay to on of we strong across cell using data are to of of each of the we profiles from of to and which small are of could a of the assay the of using profiles an of cellular to small and a new for with of the assay a the and of the assay were by processing We developed for protein digestion, phosphopeptide and using and We process monitoring enrichment to for peptide and that are to a effort. We demonstrated that we could simultaneous process 96 samples in only 3 with a plate enrichment of and ∼95% of the reduced-representation phosphopeptides in to samples using assay is a with a to data We the targeted assay and the of a reduced-representation by of set to deeper data under the conditions for discovery experiments these we were to in discovery experiments that a set of phosphopeptide probes be for a phosphopeptide are using a that and to the of and these we evaluated the performance of the assay We and cell lines and demonstrated that the is in with treatment be detected a cell and across cell We on to show that the of the profiles in the assay have and of is for of and in for in that is in the assay to and that cellular responses to are we could treatment the we of in the profiles the and that we observations changes in protein the assay We the of measuring the of the to be of the of the that we to the assay to a the of of a is a of the we the changes and the protein We that the assay represents of the experiments that are by 3 and that the the 3 and We that is the to measure phosphosignaling changes in have a to strong on the in the We the assay to to the in in in of we measured of in and we to with the of the possible in cell that we the we that of these data be treatment with the in the of cell we only data an of to phosphosignaling profiles in cell that and We that the assay be in of We demonstrated that the assay was in by data from new cell treated with the assay We were to measure phosphosignaling profiles in and in to different of a an and with cell experiments, of by across and to using data for treated and the for the assay to be in a of and We demonstrated that with of cell signaling that monitoring phosphosites is for the phosphosignaling profiles we generated from and and of reduced-representation phosphopeptide probes is to the of by of the and developed a targeted assay to responses to in a by from data A protein assay for cellular we selected probes that were highly in discovery data we selected probes to signaling the of protein selected a of probes for protein and experiments and to the we selected a set of phosphopeptide probes to with the assay, the of reduced-representation be to different of probes be detected and have varying responses to reduced-representation to probes to to the to measure across the the of the is to that the of the reduced-representation set was data of cellular pathways This is on of we that by that phosphosites with a of in the the of the cellular to that to responses to that the is to of and to of cellular the discovery data to the assay a of that to be that the assay these pathways by the the selected probes have to the discovery pathways by are in Many of these cell signaling pathways have been in and are of to and the signaling been in and of of signaling pathways in of in and been to and protein signaling cell and in and protein the process an signaling signaling is with and a of signaling and targeted we have demonstrated that the assay is sensitive to disruptions of the MAPK, PI3K/mTOR, and cell to these pathways these experiments, we in these signaling pathways and that allowed to the the of the from and with of of and which to of the data the assay samples and of to and the pathways by the that the assay is a proxy for monitoring cellular processes. to in these pathways is in with the pathways which we the assay on the is for phosphosignaling assay in the for possible be a assay that and of analytes the to data for phosphopeptide analytes of in assay is a on is to be in with gene expression to develop of cellular responses to be to data on in assay the of by targeted parallel reaction monitoring modifications on the with of that are directly targeted by the with of process that be of of signaling responses for these We to by with under the of the of to data from a set of and across a of cell A of these data been in of We that these of data of and phosphosignaling to we developed and a assay that be a to the of on cell signaling in cell assay we demonstrated that reduced-representation are by in discovery We cell signaling in a assay and demonstrated that is and We were to that are to the that have signaling we the assay a of data that be to phosphosignaling profiles by only phosphopeptide probes are we demonstrated the of studies by a MS assay that be a that the to thousands of with be an from the to of the of cellular and to We for to data We for with